These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35637356)

  • 21. Targeting STING for cancer immunotherapy: From mechanisms to translation.
    Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.
    Bode C; Fox M; Tewary P; Steinhagen A; Ellerkmann RK; Klinman D; Baumgarten G; Hornung V; Steinhagen F
    Eur J Immunol; 2016 Jul; 46(7):1615-21. PubMed ID: 27125983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
    Guo J; Huang L
    Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent progress on the activation of the cGAS-STING pathway and its regulation by biomolecular condensation.
    Yu X; Zhao Z; Jiang Z
    J Mol Cell Biol; 2022 Nov; 14(6):. PubMed ID: 35803579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
    Li A; Yi M; Qin S; Song Y; Chu Q; Wu K
    J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conserved strategies for pathogen evasion of cGAS-STING immunity.
    Eaglesham JB; Kranzusch PJ
    Curr Opin Immunol; 2020 Oct; 66():27-34. PubMed ID: 32339908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cGAS-STING Pathway in Bacterial Infection and Bacterial Immunity.
    Liu N; Pang X; Zhang H; Ji P
    Front Immunol; 2021; 12():814709. PubMed ID: 35095914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
    Pépin G; Gantier MP
    Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pleiotropic roles of cGAS-STING signaling in the tumor microenvironment.
    Li J; Bakhoum SF
    J Mol Cell Biol; 2022 Aug; 14(4):. PubMed ID: 35325182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A non-nucleotide agonist that binds covalently to cysteine residues of STING.
    Matsumoto K; Ni S; Arai H; Toyama T; Saito Y; Suzuki T; Dohmae N; Mukai K; Taguchi T
    Cell Struct Funct; 2023 Feb; 48(1):59-70. PubMed ID: 36575042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cGAS facilitates sensing of extracellular cyclic dinucleotides to activate innate immunity.
    Liu H; Moura-Alves P; Pei G; Mollenkopf HJ; Hurwitz R; Wu X; Wang F; Liu S; Ma M; Fei Y; Zhu C; Koehler AB; Oberbeck-Mueller D; Hahnke K; Klemm M; Guhlich-Bornhof U; Ge B; Tuukkanen A; Kolbe M; Dorhoi A; Kaufmann SH
    EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30872316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
    Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
    Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insight into the dichotomous regulation of STING activation in immunotherapy.
    Hu Z; Yang Y; Fang L; Zhou J; Zhang H
    Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
    Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
    Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
    Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
    Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
    Corrales L; Gajewski TF
    Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.